Koller L, Kleber M, Goliasch G, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer T, Delgado G et al.
Among 459 HFpEF patients in LURIC followed for a median of 9.7 years, CRP independently predicted all-cause mortality (HR 1.20 per SD, 95% CI 1.02-1.40, p = 0.018) and cardiovascular mortality (HR 1.32, 95% CI 1.08-1.62, p = 0.005), with a stronger effect than in 522 HFrEF controls (interaction p = 0.015). Combined with Nt-proBNP, CRP stratified 5-year mortality from 6.8% to 36.5%, suggesting inflammatory processes drive HFpEF prognosis.
European Journal of Heart Failure, 7. Mai 2014 | PMID 24806206